Serum Institute of India Seeks DCGI Nod For COVID-19 Vaccine COVOVAXPTISaturday, October 30, 2021 10:03 AM IST
Serum Institute Receives Approval To Launch Covovax Trials On Children Aged 7-11Bhaswati Guha Majumder Wednesday, September 29, 2021 04:37 PM IST
US Pharma Major J&J Seeks Emergency Use Approval For Its Single-Shot COVID-19 Vaccine In IndiaSwarajya StaffFriday, August 6, 2021 04:14 PM IST
Novavax Is Facing Funding Issues In The US But Seeking Emergency Approval In Needy CountriesBhaswati Guha Majumder Friday, August 6, 2021 02:08 PM IST
Novavax Seeks DCGI's Approval For Emergency Use Of Its Covid-19 Vaccine In IndiaSwarajya StaffFriday, August 6, 2021 09:29 AM IST
Serum Institute Begins Advance Production Of Its Upcoming Second Covid-19 Vaccine NovavaxSwarajya StaffSaturday, June 26, 2021 09:29 AM IST
All You Need To Know About Four Covid-19 Vaccine Candidates In India For ChildrenBhaswati Guha Majumder Friday, June 18, 2021 04:49 PM IST
Serum Institute Likely To Begin Clinical Trial Of Covovax On Children In India From Next Month: ReportSwarajya StaffFriday, June 18, 2021 04:18 PM IST
Amid Looming Uncertainty Over EUA In US, Novavax Eyes India Launch Of Its COVID Jab With Over 90 Per Cent EfficacySwarajya StaffTuesday, June 15, 2021 03:06 PM IST
Novavax Covid-19 Vaccine Is About 90 Per Cent Effective, Finds Large StudyBhaswati Guha Majumder Monday, June 14, 2021 05:40 PM IST
We Are Out Of Vaccine Panic Mode; Pfizer, Moderna Can’t Dictate Terms Any MoreR JagannathanWednesday, June 9, 2021 10:58 AM IST
From Novavax To Sanofi, Pharmaceutical Companies Develop A New Type Of Covid-19 Vaccine Bhaswati Guha Majumder Monday, June 7, 2021 08:02 PM IST
In A Setback To Global Vaccine Drive, Novavax Reports Further Delays In Approval And Production Of Covid-19 Vaccine
Swarajya StaffWednesday, May 12, 2021 09:58 AM IST
US-Based Novavax Begins Clinical Trials Of Its COVID-19 Vaccine Candidate On Adolescents Aged Between 12 To 17 YearsSwarajya StaffTuesday, May 4, 2021 09:55 AM IST
How Bharat Biotech Plans To Overcome Production Challenges Due To Export Restrictions On Raw Materials By US Bhaswati Guha MajumderThursday, April 15, 2021 02:27 PM IST
Serum Institute Begins Phase Two And Three Bridging Trials Of Covid-19 Vaccine Candidate Covovax In IndiaSwarajya StaffSaturday, March 27, 2021 11:36 AM IST
Novavax, J&J Covid-19 Vaccines Show Encouraging Results In Phase 3 TrialsSwarajya StaffSaturday, January 30, 2021 02:34 PM IST
‘Made In India’ Covaxin’s Phase-1 Trial Results Are Out And They Are PromisingSwarajya StaffFriday, December 18, 2020 05:24 PM IST
ICMR, Serum Institute Complete Enrolment In Phase 3 Clinical Trials For Covid-19 Vaccine 'Covishield'Swarajya StaffThursday, November 12, 2020 11:32 AM IST
Government Secures Vaccine Supplies For Half Of The Indian Population From Serum Institute And Novavax: ReportSwarajya StaffTuesday, November 3, 2020 09:13 AM IST